Application of graphite-phase carbon nitride as antibacterial agent in dental light-cured composite resin, dental composite resin and preparation method of dental composite resin

By using graphite phase carbon nitride and barium glass powder in dental photocuring composite resin, the problem of microcracking composite resins that is prone to microcracks and lack of antibacterial properties in dental repair is solved, and the photodynamic antibacterial effect and mechanical properties are achieved.

CN118903413APending Publication Date: 2024-11-08BEIJING UNIV OF CHEM TECH +1
View PDF 2 Cites 0 Cited by

Patent Information

Application Number
CN202410921793.4
Authority / Receiving Office
CN · China
Patent Type
Applications(China)
Current Assignee / Owner
Filing Date
2024-07-10
Publication Date
2024-11-08

AI Technical Summary

Technical Problem

Existing photocuring composite resins are prone to microcracks when repairing teeth, resulting in secondary caries and lack antibacterial properties. Release antibacterial agents have problems with concentration reduction and cytotoxicity, while intrinsic antibacterial agents do not have advantages in mechanical properties. .

Method used

Introduce graphite phase carbon nitride (g-C3N4) as a photodynamic antibacterial agent in dental photocuring composite resin, and control its incorporation of reactive oxygen species under light. content to ensure mechanical properties and fluidity.

Benefits of technology

The photodynamic antibacterial effect of the composite resin is achieved, avoiding the reduction of the concentration of the release antibacterial agent and the cytotoxicity problems, while maintaining the mechanical properties and biocompatibility of the composite resin.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure BDA0004936925330000071
    Figure BDA0004936925330000071
  • Figure BDA0004936925330000081
    Figure BDA0004936925330000081
  • Figure HDA0004936925350000011
    Figure HDA0004936925350000011
Patent Text Reader

Abstract

The invention relates to the technical field of dental restoration materials, and particularly discloses application of graphite-phase carbon nitride as an antibacterial agent in dental light-cured composite resin, the dental composite resin and a preparation method of the dental composite resin. The invention discloses application of graphite-phase carbon nitride as a photodynamic antibacterial agent in dental photocuring composite resin. Meanwhile, the dental composite resin with the photodynamic antibacterial effect, provided by the invention, comprises the graphite phase carbon nitride. The photodynamic antibacterial filler is added into the dental composite resin, so that the dental composite resin has a photodynamic antibacterial effect. The excitation light source is convenient, easy-to-obtain and clean sunlight; after illumination, active oxygen is generated for sterilization, so that the bacteria cannot generate drug resistance, and the mechanical property and biocompatibility of the dental composite resin are not influenced by the addition of the photodynamic antibacterial filler.
Need to check novelty before this filing date? Find Prior Art

Description

Technical Field

[0001] The present application relates to the technical field of dental restorative materials, and more specifically, to the application of graphite phase carbon nitride as an antibacterial agent in dental light-curing composite resins, dental composite resins and preparation methods thereof. Background Art

[0002] Dental caries is a common oral disease and one of the most common diseases in humans. In the process of dental caries treatment, the use of light-cured composite resin restoration is the most commonly used method. However, due to the characteristics of polymerization shrinkage, light-cured composite resins are prone to produce microcracks after the restoration, which in turn causes secondary dental caries. At the same time, the light-cured composite resins currently used on the market lack antibacterial properties. Therefore, one of the research directions to reduce the occurrence of secondary dental caries is to give light-cured composite resins antibacterial properties.

[0003] At present, antimicrobial agents are mainly divided into release-type antimicrobial agents and intrinsic antimicrobial agents.

[0004] For release-type antimicrobial agents, on the one hand, the concentration of the release-type antimicrobial agents inside the composite resin will decrease with the extension of the release time; on the other hand, there will be an explosive release in the early stage of the release-type antimicrobial agents taking effect, which may produce cytotoxicity; at the same time, after the release-type antimicrobial agents are released, they may also cause a decrease in the mechanical properties of the composite resin.

[0005] For intrinsic antibacterial agents, there are no above-mentioned problems of release antibacterial agents in the antibacterial process. Intrinsic antibacterial agents can be divided into contact antibacterial agents, piezoelectric catalytic antibacterial agents and photodynamic antibacterial agents according to the principle of antibacterial action. Contact antibacterial agents include quaternary ammonium salts (QACs) and imidazoles. Although the detailed mechanism of the antibacterial effect of quaternary ammonium compounds has not yet been determined, it is generally believed that the positive potential point (N+) of QACs and negatively charged bacteria react, and the long lipophilic alkyl chain destroys the cell wall, resulting in leakage, autolysis and death of bacterial cytoplasmic substances. However, this type of antibacterial agent needs to be grafted onto the resin monomer to synthesize new monomers. The introduction of quaternary ammonium salts may increase the hydrophilicity of the resin, facilitate bacterial adhesion and bring about disadvantages such as cytotoxicity. Photodynamic antibacterial agents can produce ROS for sterilization under light conditions, have broad-spectrum antibacterial properties, and can kill various bacteria on and around the resin surface. The particles will not fall out of the resin, have persistent antibacterial properties, and will not cause a decrease in mechanical properties. The oral cavity is an open environment, and the light source can easily reach the lesion site for in situ treatment. Therefore, photodynamic antimicrobial agents are currently more widely welcomed. Summary of the invention

[0006] Provided are an application of graphite phase carbon nitride as an antibacterial agent in a dental light-cured composite resin, a dental composite resin and a preparation method thereof.

[0007] In a first aspect, the present application provides a use of graphite carbon nitride as a photodynamic antibacterial agent in dental light-cured composite resin.

[0008] In the second aspect, the present application provides a dental composite resin with photodynamic antibacterial effect, which adopts the following technical solution:

[0009] A dental composite resin with photodynamic antibacterial effect comprises the above-mentioned graphite phase carbon nitride.

[0010] Optionally, a reinforcing filler is further included; the total weight of the graphite carbon nitride and the reinforcing filler accounts for 65-75wt% of the dental composite resin.

[0011] In a specific embodiment, the total weight of the graphite carbon nitride and the reinforcing filler accounts for 70 wt % of the dental composite resin.

[0012] In the present application, when the total weight of graphite phase carbon nitride and reinforcing agent accounts for a small weight percentage of the dental composite resin, the mechanical properties of the dental composite resin will be affected. Specifically, when the total weight of the two accounts for less than 60wt% of the weight percentage of the dental composite resin, the dental composite resin cannot achieve the required mechanical properties after curing.

[0013] When the total weight of graphite phase carbon nitride and reinforcing agent is too high in the weight percentage of dental composite resin, the fluidity of dental composite resin will be affected. Specifically, when the total weight of the two is greater than 80wt% of the weight percentage of dental composite resin, the fluidity of dental composite resin is poor, and the dental composite resin cannot be well filled when making tooth restoration. Therefore, the total weight of graphite phase carbon nitride and reinforcing agent is controlled at 65-75wt% of the weight percentage of dental composite resin.

[0014] Optionally, the weight ratio of the graphite phase carbon nitride to the reinforcing filler is 1:(6-69).

[0015] In a specific embodiment, the weight ratio of the graphite phase carbon nitride to the reinforcing filler is 1:69.

[0016] In a specific embodiment, the weight ratio of the graphite phase carbon nitride to the reinforcing filler is 5:65.

[0017] In a specific embodiment, the weight ratio of the graphite phase carbon nitride to the reinforcing filler is 10:60.

[0018] Optionally, the weight percentage of the graphite phase carbon nitride in the dental composite resin is 1-10 wt %.

[0019] In a specific embodiment, the weight percentage of the graphite phase carbon nitride in the dental composite resin is 1 wt %.

[0020] In a specific embodiment, the weight percentage of the graphite carbon nitride in the dental composite resin is 5 wt %.

[0021] In a specific embodiment, the weight percentage of the graphite phase carbon nitride in the dental composite resin is 10 wt %.

[0022] Optionally, the particle size of the graphite phase carbon nitride particles is in the range of 600-1000 nm.

[0023] Optionally, the reinforcing material is barium glass powder.

[0024] This application uses graphite carbon nitride (g-C3N4) as a photosensitizer to study its antibacterial effect in dental composite resins. g-C3N4 has good thermal / chemical stability and biocompatibility, and its color matches the color of the resin, so g-C3N4 has become a new antibacterial filler choice for composite resins.

[0025] g-C3N4 is a metal-free polymer with a graphene phase structure, in which both C and N atoms are sp2 hybridized to form aromatic CN hexacyclic rings. It has a highly delocalized π-electron conjugated system in its two-dimensional network structure. g-C3N4 is a stacked 2D layered structure with a 0.326nm interplanar spacing, and these layered structures are bound by weak interactions. g-C3N4 has a rigid hexacyclic CN heterocyclic structure, a highly conjugated system, and a high degree of condensation, and has extremely high thermal and chemical stability. The heat resistance of g-C3N4 is as high as 600°C, and it is also insoluble in water, most acids, bases, and various organic solvents.

[0026] The antibacterial principle of g-C3N4 is as follows: After g-C3N4 absorbs photons of sufficient energy, it excites electrons (e-) to jump from the valence band (Vb) to the conduction band (Cb), leaving positively charged holes (h+) in the valence band. The band gap of g-C3N4 is about 2.7eV, which means that g-C3N4 can be activated by light with a wavelength below about 459nm. Then the electrons and holes can migrate freely from the particles. When migrating out of the particle surface, the electrons and holes can undergo redox reactions with water and oxygen on the particle surface to produce superoxide radicals. Hydroxyl (·OH), singlet oxygen ( 1The generated ROS will react with organic matter such as bacterial cell walls and cell membranes, causing them to degrade, intracellular substances to leak, and then the cells to die. However, if electrons and holes meet inside the particles, they will recombine and release energy in the form of light or heat. During the antibacterial process, g-C3N4 will not be released in the oral cavity, so the antibacterial activity will not decrease with the release time like the release-type antibacterial agent, and the cytotoxicity caused by the explosive release is also avoided. g-C3N4 produces ROS for antibacterial, has a broad spectrum of antibacterial activity against Gram-negative and Gram-positive bacteria, and will not cause bacterial resistance like organic antibacterial agents. g-C3N4 has a color that matches the composite resin, and has excellent photodynamic antibacterial ability, broad-spectrum antibacterial activity, thermal / chemical stability, and good biocompatibility after being excited by sunlight. It is expected to be used as a photodynamic antibacterial agent in dental composite resins.

[0027] In a third aspect, the present application provides a method for preparing a dental composite resin having a photodynamic antibacterial effect, using the following technical solution:

[0028] A method for preparing a dental composite resin having a photodynamic antibacterial effect, the preparation method specifically comprising the following steps:

[0029] Firstly, graphite phase carbon nitride and anhydrous ethanol are made into a suspension, and then barium glass powder and triethylene glycol dimethacrylate are added thereto and stirred evenly; a main initiator and a co-initiator are added and stirred evenly; bisphenol A glycidyl methacrylate is added and stirred evenly to prepare a dental composite resin.

[0030] In the present application, since the viscosity of triethylene glycol dimethacrylate is relatively low, while the viscosity of bisphenol A glycidyl methacrylate is relatively high, the order of adding triethylene glycol dimethacrylate and bisphenol A glycidyl methacrylate into the composite resin matrix is: first adding triethylene glycol dimethacrylate, and then adding bisphenol A glycidyl methacrylate. The triethylene glycol dimethacrylate with a lower viscosity is easy to mix well with the filler. After the triethylene glycol dimethacrylate and the filler are fully mixed, the bisphenol A glycidyl methacrylate with a higher viscosity is added. When the stirring is completed, the anhydrous ethanol in the system is completely volatilized.

[0031] Optionally, in the composite resin matrix, the weight ratio of the bisphenol A glycidyl methacrylate to the triethylene glycol dimethacrylate is (1-2):1.

[0032] In the present application, the bisphenol A glycidyl methacrylate used has a large density and high viscosity, which makes it difficult to mix the filler evenly. However, the bisphenol A glycidyl methacrylate molecule contains rigid groups, which can make the resin have smaller polymerization shrinkage performance and better mechanical properties after curing. The triethylene glycol dimethacrylate used has a low viscosity and is often used as a diluent. After the composite resin is mixed with triethylene glycol dimethacrylate, the composite resin matrix has better uniformity. Therefore, in the composite resin matrix of the present application, bisphenol A glycidyl methacrylate is used as the main resin matrix to ensure that the resin has better polymerization shrinkage and mechanical properties, and triethylene glycol dimethacrylate is used as a diluent to make the system mixing more uniform. At the same time, when the weight ratio of bisphenol A glycidyl methacrylate and triethylene glycol dimethacrylate is less than 1:1, it will affect the polymerization shrinkage and mechanical properties of the composite resin matrix; when the weight ratio of bisphenol A glycidyl methacrylate and triethylene glycol dimethacrylate is greater than 2:1, the system is too viscous, affecting the uniformity of the composite resin matrix. Therefore, the weight ratio of bisphenol A glycidyl methacrylate to triethylene glycol dimethacrylate is set to (1-2):1.

[0033] Optionally, the primary initiator accounts for 1-2 wt % of the total weight of the composite resin matrix.

[0034] In a specific embodiment, the primary initiator accounts for 1.5 wt % of the total weight of the composite resin matrix.

[0035] Optionally, the main initiator is camphorquinone.

[0036] Optionally, the co-initiator accounts for 1-2 wt % of the total weight of the composite resin matrix.

[0037] In a specific embodiment, the co-initiator accounts for 1.5 wt % of the total weight of the composite resin matrix.

[0038] Optionally, the co-initiator is ethyl 4-diaminobenzoate.

[0039] In summary, this application has the following beneficial effects:

[0040] The present application adds a photodynamic antibacterial filler, graphite phase carbon nitride (g-C3N4), to a dental composite resin, so that the dental composite resin has a photodynamic antibacterial effect. The excitation light source is convenient, easily available and clean sunlight; the active oxygen generated after illumination will kill bacteria without causing drug resistance, and the addition of the photodynamic antibacterial filler does not affect the mechanical properties and biocompatibility of the dental composite resin. BRIEF DESCRIPTION OF THE DRAWINGS

[0041] Figure 1This is the XRD detection spectrum of BCN provided in the preparation example of this application.

[0042] Figure 2 This is the FTIR detection spectrum of BCN provided in the preparation example of this application.

[0043] Figure 3 Thermogravimetric analysis of BCN provided in the preparation example of this application.

[0044] Figure 4 The results of degradation of organic dye Rhodamine B by BCN under visible light irradiation provided in the preparation examples of this application ((a) control group without BCN; (b) test group with BCN).

[0045] Figure 5 The dental composite resin provided in Example 2 of the present application generates ROS under visible light irradiation (a) 1 O2 production; The production of OH).

[0046] Figure 6 The antibacterial effect of dental composite resins with different BCN contents ((a) S. aureus, Staphylococcus aureus; (b) S. mutans, Streptococcus mutans).

[0047] Figure 7 Biocompatibility test results of dental composite resins with different BCN contents (CCK-8).

[0048] Figure 8 These are the test results of mechanical properties of dental composite resins with different BCN contents (without ethanol separation).

[0049] Fig. 9 The mechanical properties test results of dental composite resins with different BCN contents (after ethanol separation) ((a) flexural strength; (b) flexural modulus). DETAILED DESCRIPTION

[0050] Before describing the embodiments of the present application in detail, it should be understood that the terms used herein are only for the purpose of describing specific embodiments. Unless otherwise defined, all technical and scientific terms used herein have the same meaning as those generally understood by ordinary technicians in the field to which the terms belong.

[0051] The present application provides the use of graphite phase carbon nitride as a photodynamic antibacterial agent in dental light-curing composite resin.

[0052] The present application also provides a dental composite resin with photodynamic antibacterial effect including the above-mentioned graphite phase carbon nitride. The above-mentioned dental composite resin also includes a reinforcing filler. The total weight of the graphite phase carbon nitride and the reinforcing filler accounts for 65-75wt% of the dental composite resin. The weight ratio of the graphite phase carbon nitride to the reinforcing filler is 1:(6-69). The weight percentage of the graphite phase carbon nitride in the dental composite resin is 1-10wt%. Further, the reinforcing material can be barium glass powder. The particle size range of the graphite phase carbon nitride particles is 600-1000nm.

[0053] The present application also provides a method for preparing a dental composite resin having a photodynamic antibacterial effect, the preparation method specifically comprising the following steps:

[0054] Firstly, graphite phase carbon nitride and anhydrous ethanol are made into a suspension, and then barium glass powder and triethylene glycol dimethacrylate are added thereto and stirred evenly; a main initiator and a co-initiator are added and stirred evenly; bisphenol A glycidyl methacrylate is added and stirred evenly to prepare a dental composite resin.

[0055] Wherein, the weight ratio of bisphenol A glycidyl methacrylate to triethylene glycol dimethacrylate is (1-2):1.

[0056] The main initiator accounts for 1-2wt% of the total weight of the composite resin matrix. The main initiator can be camphorquinone.

[0057] The co-initiator accounts for 1-2 wt % of the total weight of the composite resin matrix. The co-initiator may be ethyl 4-diaminobenzoate.

[0058] To make the purpose, technical solutions and advantages of this application clearer, the technical solutions in the embodiments of this application are described clearly and completely below. Based on the embodiments of this application, all other embodiments obtained by those skilled in the art without creative work are within the scope of protection of this application.

[0059] The present application is further described in detail below in conjunction with the embodiments and performance test results.

[0060] Preparation Example

[0061] This preparation example provides a preparation method of BCN (bulk graphite carbon nitride, Bulk g-C3N4). BCN is prepared by thermal polycondensation.

[0062] The preparation method specifically includes the following steps: placing 20 g of melamine in a 50 mL alumina crucible with a lid, and then placing it in a muffle furnace and heating it to 550 ° C at 5 ° C / min, keeping it warm for 4 hours to obtain a light yellow block solid, and then ball milling to obtain a powder, which is bulk graphite phase carbon nitride, denoted as Bulk g-C3N4, abbreviated as BCN.

[0063] Example

[0064] Example 1

[0065] This embodiment provides a dental composite resin with photodynamic antibacterial effect. The BCN used is the BCN prepared in the preparation example. The parameters involved in the preparation method are specifically shown in Table 1.

[0066] The method for preparing the above-mentioned dental composite resin with photodynamic antibacterial effect specifically comprises the following steps:

[0067] (1) First, place BCN (photodynamic antibacterial agent) and 30 mL of anhydrous ethanol in a 150 mL beaker and disperse them by ultrasonication for 30 min. Take the upper suspension as the effective ingredient. Dry the BCN remaining in the beaker after ultrasonication and calculate the weight of BCN in the upper suspension. From this, calculate the required amount of the remaining parts.

[0068] (2) Add barium glass powder (reinforcement filler, particle size about 0.7 μm) to the above suspension and continue ultrasonic mixing for 15 minutes.

[0069] (3) Continue to add diluted resin-triethylene glycol dimethacrylate (TEGDMA) and stir mechanically for 12 hours.

[0070] (4) Continue to add 1.5 wt% of camphorquinone (CQ) as a main initiator and 1.5 wt% of ethyl 4-diaminobenzoate (EDB) as a co-initiator based on the total weight of the composite resin matrix, and continue mechanical stirring for 12 h.

[0071] (5) Finally, bisphenol A glycidyl methacrylate (Bis-GMA) was added, and mechanical stirring was performed for 12 hours, and finally a three-roller was used to mix the sample more evenly to obtain a dental composite resin. After stirring, the anhydrous ethanol in the system evaporated completely.

[0072] The above dental composite resin was filled into the mold and light cured in a curing box for 20 seconds on each side. After curing, it was placed in a 37°C water bath for secondary curing for 24 hours. After curing, the sample strips / samples were taken out and polished with sandpaper, and then polished with 400 mesh, 600 mesh, 1000 mesh and 2000 mesh sandpaper.

[0073] The three-point bending mold is made according to the requirements of standard YY-1024. The length, width and height of the sample mold are 25mm, 2mm and 2mm respectively. The circular sample mold used for antibacterial, EPR and biocompatibility testing has a diameter of 10mm and a height of 3mm.

[0074] Example 2-3

[0075] Embodiments 2-3 respectively provide a dental composite resin with photodynamic antibacterial effect. The difference between the above embodiments and embodiment 1 is that the parameters involved in the preparation method of the dental composite resin are different, specifically the percentage of BCN is different, and the rest are consistent with embodiment 1.

[0076] Comparative Example

[0077] Comparative Example 1

[0078] Comparative Example 1 provides a dental composite resin with photodynamic antibacterial effect. The difference between this comparative example and Example 2 is that only barium glass powder is included, and BCN is not included. The rest is consistent with Example 2.

[0079] Comparative Example 2

[0080] Comparative Example 2 provides a dental composite resin with photodynamic antibacterial effect. The difference between this comparative example and Example 1 is that in step (1), BCN is not separated by ethanol, and the rest is the same as Example 1.

[0081] The specific operation of step (1) of comparative example 2 is: adding BCN into anhydrous ethanol solution and mixing evenly to obtain a suspension.

[0082] Comparative Example 3

[0083] Comparative Example 3 provides a dental composite resin with photodynamic antibacterial effect. The difference between this comparative example and Example 2 is that the treatment of BCN in step (1) is consistent with the corresponding step in Comparative Example 2, ethanol separation is not used, and the rest is consistent with Example 2.

[0084] Comparative Example 4

[0085] Comparative Example 4 provides a dental composite resin with photodynamic antibacterial effect. The difference between this comparative example and Example 3 is that the treatment of BCN in step (1) is consistent with the corresponding step in Comparative Example 2, ethanol separation is not used, and the rest is consistent with Example 3.

[0086] Comparative Example 5

[0087] Comparative Example 5 provides a dental composite resin with photodynamic antibacterial effect. The difference between this comparative example and comparative example 1 is that the treatment of BCN in step (1) is consistent with the corresponding step in comparative example 2, ethanol separation is not used, and the rest is consistent with comparative example 1.

[0088] Table 1 Parameters involved in the preparation method of dental composite resin provided in the examples and comparative examples of the present application

[0089]

[0090]

[0091] Detection test

[0092] (I) About BCN detection

[0093] (1) XRD detection of BCN

[0094] The BCN prepared in the preparation example was subjected to XRD detection. The detection method is as follows:

[0095] Take 0.1g of the powder sample ground in the preparation example and analyze and detect the powder sample on an X-ray diffractometer. Use a Cμ target, an acceleration voltage of 40kV, a tube current of 200mA, a scanning speed of 10° / min, and an angle of 5-90°.

[0096] Test results such as Figure 1 shown.

[0097] like Figure 1 As shown, the XRD detection spectrum of the powder sample provided in the preparation example has two obvious characteristic peaks. The low angle of 13.1° is the (100) crystal plane, which is the characteristic peak of the orderly repeated connection of the 3-s-triazine ring structure, and the (002) crystal plane characteristic peak at 27.5° is a typical interlayer stacking characteristic peak. This indicates that the powder sample provided in the preparation example is BCN, indicating that BCN was successfully prepared.

[0098] (2) FTIR detection of BCN

[0099] The BCN prepared in the preparation example was tested by FTIR. The test method is as follows:

[0100] Before testing, the ground powder sample of the preparation example was placed in an oven and dried overnight at 80°C to remove free water in the powder sample. A small amount of the dried powder sample was mixed with potassium bromide powder at a weight ratio of 1:100, pressed into tablets, and placed in an infrared spectrometer for characterization at 4000 cm -1 -500cm -1 Scanning range, resolution 2cm -1 .

[0101] Test results such as Figure 2 shown.

[0102] The crystal structure of BCN can be further confirmed by FTIR detection spectrum. Figure 2 As shown, 3000cm -1 -3500cm -1 , is the characteristic peak of the sample NH, 1241cm -1 、1317cm -1 、1408cm-1 、1558cm -1 and 1640cm -1 It is a typical stretching vibration peak of CN heterocycle, and 810cm -1 Nearby is the bending vibration peak of the 3-s-triazine ring.

[0103] (3) Thermogravimetric analysis of BCN

[0104] The BCN prepared in the preparation example was subjected to thermogravimetric analysis. The analysis method is as follows:

[0105] 5-10 mg of the ground powder sample of the preparation example was weighed and placed in an alumina crucible. The temperature was raised from room temperature (25°C) to 800°C at a rate of 5°C / min in a nitrogen atmosphere for thermogravimetric analysis.

[0106] Test results such as Figure 3 shown.

[0107] like Figure 3 As shown in the figure, when heated to 600°C, the BCN powder sample begins to decompose, with the maximum decomposition rate at 770°C. When the temperature is heated to 800°C, the BCN powder sample is basically decomposed, indicating that the prepared BCN has good thermal stability.

[0108] (4) BCN dye degradation test

[0109] The BCN prepared in the preparation example was subjected to a dye degradation test.

[0110] The test method is as follows:

[0111] Weigh 50 mg of the powder sample ground in the preparation example and add it to 50 mL of 10 mg / L Rhodamine B aqueous solution, and stir it in a dark environment for 2 hours until the powder sample and Rhodamine B reach an adsorption-desorption equilibrium state. Take a parallel sample of Rhodamine B dye before mixing with the powder sample and record it as -120 min. Under visible light irradiation (200 mW / cm 2 , full spectrum) at 0min, 10min, 20min, 30min, 40min, 50min, and 60min, parallel samples were quickly taken and numbered, and stored in dark conditions.

[0112] A control group was set up, that is, a visible light catalytic degradation test was carried out on an aqueous solution of Rhodamine B without the powder sample ground after the preparation example, while other conditions remained unchanged, to explore whether visible light irradiation has a degradation effect on pure Rhodamine B dye.

[0113] After the experiment, each group of samples was centrifuged at 12000 r / min for 3 min, 100 μL of supernatant was aspirated into a 96-well plate and the absorbance of the supernatant was tested using a multifunctional microplate reader with a spectral scanning range of 450 nm-650 nm and a scanning interval of 5 nm.

[0114] Test results such as Figure 4 shown.

[0115] Depend on Figure 4 It can be seen that in the control group without BCN ( Figure 5 (a)), after 60 minutes of illumination, the absorbance did not decrease significantly, that is, the dye did not degrade significantly, indicating that visible light irradiation has no degradation effect on pure rhodamine B dye. Figure 5 In (b), after 60 min of illumination, the absorbance decreased significantly and the dye was degraded by 67.7%, indicating that BCN has good organic matter degradation ability under visible light irradiation.

[0116] (II) Testing of dental composite resins

[0117] (1) Electron paramagnetic resonance characterization of dental composite resins

[0118] The dental composite resin provided in Example 2 was characterized by electron paramagnetic resonance.

[0119] Electron Paramagnetic Resonance (EPR) is a magnetic resonance technique originated from the magnetic moment of unpaired electrons. It can be used to detect the unpaired electrons contained in atoms or molecules of substances from qualitative and quantitative aspects, and explore the structural characteristics of their surroundings. For free radicals, the orbital magnetic moment has almost no effect, and the vast majority (more than 99%) of the total magnetic moment comes from the electron spin, so electron paramagnetic resonance is also called "electron spin resonance" (ESR).

[0120] Most free radicals are substances with very short life spans, so it is necessary to select a scavenger corresponding to the free radical. The scavenger forms an adduct with the free radical, which can greatly prolong the existence time of the free radical. Here, 5,5-dimethyl-1-pyrrole-N-oxide (DMPO) is selected as the superoxide free radical. and hydroxyl radical (OH) scavengers, 2,2,6,6-tetramethylpiperidinyl oxide (TEMP) was selected as the singlet oxygen ( 1 O2) capture agent can capture the adduct with characteristic EPR signal, and detect the free radical signal by detecting the characteristic peak signal through EPR.

[0121] The characterization method is as follows:

[0122] Preparation of capture agent: Take 5.5 μL of DMPO mother solution and add it to 250 μL of corresponding solvent to prepare a 0.2M solution; OH is generally captured in aqueous solution, O 2- Typically captured in methanol solution.

[0123] Sample preparation: The dental composite resin provided in Example 2 was immersed in 1 mL of the corresponding capture agent solution as the test solution.

[0124] Detection of hydroxyl radicals (OH) or superoxide radicals Take 200mL of the prepared DMPO solution and add it to 1000μL of the test solution. Use EPR to test the generation of hydroxyl radicals and superoxide radicals at 0min, 3min and 5min of illumination.

[0125] Detection of singlet oxygen ( 1 O2): Take 100 μL of TEMP mother solution and add it to 1000 μL of the test solution, and use EPR to test the generation of singlet oxygen when irradiated for 0 min, 3 min and 5 min.

[0126] Test results such as Figure 5 shown.

[0127] Depend on Figure 5 It can be seen that when the test solution was without light (0min), no active oxygen was detected; when there was visible light irradiation, obvious ·OH, 1 O2 active oxygen signal; and with the increase of illumination time, the signal peak of active oxygen increases, indicating that the amount of active oxygen generated by the dental composite resin in the test solution increases. This shows that the sample can produce ·OH, 1 O2, and continuous light will continue to stimulate BCN to produce OH, 1 Therefore, the dental composite resin provided by the present application is beneficial to the degradation of organic pollutants and has an antibacterial effect.

[0128] (2) Antibacterial testing of dental composite resins

[0129] The dental composite resins prepared in Examples 1-3 and Comparative Example 1 were subjected to antibacterial tests.

[0130] The test method is as follows:

[0131] 1) Preparation of bacterial culture medium

[0132] The formula and preparation method of LB liquid culture medium are as follows: add 10g of tryptone, 5g of yeast powder, and 10g of NaCl to 1000mL of deionized water, and then place it in a high-temperature sterilizer and treat it at high temperature and high pressure at 126°C for 20min to obtain a light yellow transparent solution.

[0133] The formula and preparation method of LB solid medium are as follows: add 10g tryptone, 5g yeast powder, 10g NaCl and 15g agar powder to 1000mL deionized water, and then place it in a high temperature sterilizer and treat it at high temperature and high pressure at 126℃ for 20min to obtain a light yellow transparent solution. When the liquid cools to about 50℃, take 20mL and pour it into a culture dish, and cool it naturally at room temperature until it is completely solidified to obtain a solid medium.

[0134] The formula and preparation method of BHI liquid culture medium are as follows: according to the instructions, weigh 52 g of powder and add it to 1000 mL of deionized water, stir evenly and then place it in a high-temperature sterilizer and treat it at high temperature and high pressure at 126°C for 20 minutes to obtain a yellow-brown transparent solution.

[0135] The formula and preparation method of BHI solid medium are as follows: according to the instructions, weigh 52g of powder and add it to 1000mL of deionized water, stir evenly, and then place it in a high-temperature sterilizer and treat it at high temperature and high pressure at 126℃ for 20min to obtain a yellow-brown transparent solution. When the liquid cools to about 50℃, use the prepared culture dishes to dispense it, about 20mL per dish. When it cools to room temperature and solidifies, the BHI solid medium is obtained and set aside.

[0136] 2) Agar plate test

[0137] Gram-positive bacteria Staphylococcus aureus (S. aureus) were cultured in LB liquid medium at 37°C overnight, and the bacterial concentration was determined by measuring the absorbance of the bacterial solution at 600 nm using an enzyme marker, and the bacterial concentration was adjusted to 1×10 4 CFU / mL (CFΜ, Colony-Forming Unit).

[0138] Dental composite resin samples with different BCN contents (0%, 1%, 5%, and 10%) were sterilized with an ultraviolet sterilization lamp and placed in 24-well plates. 1 mL of bacterial solution was injected to immerse the dental composite resin samples and placed under visible light (200 mW / cm 2 , full spectrum) for 30 minutes. During the illumination period, the 24-well plate was placed in a large water tank to prevent the light from raising the temperature of the bacterial solution. After the illumination was completed, 100 μL of the bacterial solution was taken and spread on the LB agar plate and cultured in a 37°C incubator for 24 hours. Three parallel samples were taken and photographed and bacteria were counted. At the same time, a non-illuminated group and a control group were set up.

[0139] The test method for Streptococcus mutans (S. mutans) is consistent with the test method for Staphylococcus aureus.

[0140] The test results are as follows Figure 6 shown.

[0141] Depend on Figure 6 It can be seen that after 30 minutes of light exposure, the antibacterial rate of the 0% BCN resin sheet was consistent with that of the Control group, and there was no obvious antibacterial effect. When the BCN content gradually increased, the antibacterial effect on S. aureus and S. mutans was significantly enhanced. The antibacterial rates of 1% BCN against S. aureus and S. mutans were 61.9% and 40.2%, respectively. The antibacterial effects of 5% BCN and 10% BCN were not much different. The antibacterial rates of 5% BCN were 99.9% and 99.5%, and the antibacterial rates of 10% BCN were 99.9% and 99.9%. The antibacterial effect of 10% BCN was not significantly stronger than that of 5% BCN, probably because the number of BCN exposed on the surface of the resin sheet was not much different, and the number of active oxygen produced after light excitation was not significantly different, so the antibacterial effects of the two were similar.

[0142] (3) CCK-8 test

[0143] The dental composite resins prepared in Examples 1-3 and Comparative Example 1 were subjected to a CCK-8 test.

[0144] According to ISO standard 10993-12, L929 mouse fibroblasts were cultured with extracts of dental composite resin samples with different BCN contents, and their proliferation was observed to characterize and evaluate the biocompatibility of the material.

[0145] The test method is as follows:

[0146] 1) Prepare the extract according to ISO 10993-12. The ratio of the surface area of ​​the dental composite resin specimen to the volume of the extract is 1.25 cm 2 / mL. First, soak the resin sample in 75% ethanol, sterilize overnight with UV light, and then soak it in sterile PBS 4 times, 1 hour each time. Then soak the resin sample in the calculated volume of cell culture fluid, and take out the resin sample after 24 hours, which is the extract of the dental composite resin sample.

[0147] 2) Cell culture: Add 20 μL of 1.5×10 5cell / mL of L929 mouse fibroblast suspension was added, and then 180 μL of the extract of dental composite resin samples with different BCN contents (0%, 1%, 5%, 10%) was added. The well plate was cultured in a cell culture incubator, and the extract of the adhesive sample was replaced every other day. CCK-8 test was performed on the 1st, 3rd and 5th days of cell culture.

[0148] 3) CCK-8 test: At the corresponding time, aspirate the liquid in the well plate, add 200 μL of 10% CCK-8 working solution, and then incubate at 37°C in the dark for 2 hours. Take out 100 μL of the liquid and add it to the ELISA plate, and detect the absorbance at 450 nm.

[0149] The test results are as follows Figure 7 shown.

[0150] Depend on Figure 7 It can be seen that during the 5 days of culturing L929 cells with extracts of dental composite resin samples with different BCN contents (0%, 1%, 5%, 10%), there was no significant difference in cell proliferation when compared with the control group in the extracts of dental composite resin samples with 0%, 1%, 5% and 10% BCN added on days 1, 3 and 5, indicating that the addition of BCN does not cause cytotoxicity to dental composite resins.

[0151] (4) Bending performance test

[0152] The samples prepared by the dental composite resins prepared in the examples and comparative examples were subjected to a three-point bending test according to standard YY 1042-2111.

[0153] The span was set to 20 mm, the test specimen was placed, and the specimen was broken with an indenter at a descending speed of 1 mm / min. The flexural strength and flexural modulus data of the test specimens prepared from dental composite resins can be obtained by three-point bending test.

[0154] The test results are shown in Table 1 and Figure 8-9 shown.

[0155] Depend on Figure 8 It can be seen that the bending strength and bending modulus of the test specimens prepared by adding different amounts of BCN (1%, 5%, 10% after ethanol separation, Examples 1-3 and Comparative Example 1) are not significantly different from those without adding BCN, indicating that the addition of BCN will not affect the bending strength and bending modulus of the dental composite resin itself.

[0156] Depend on Fig. 9It can be seen that the bending strength of the test specimens prepared by the dental composite resin without adding BCN is significantly reduced compared with the bending strength of the test specimens prepared by the dental composite resin with different contents of BCN (1%, 5%, 10% without ethanol separation, comparative examples 2-5). At the same time, compared with the bending strength of the test specimens prepared by adding BCN separated by ethanol under the same conditions, it is also significantly reduced, indicating that the ethanol separation of BCN has a great influence on the bending strength of the dental composite resin.

[0157] Further analysis of the effect of ethanol separation on BCN revealed that ethanol separation can make BCN have a more uniform particle size distribution. DLS spectrum analysis showed that the diameter of BCN particles after ethanol separation was mainly distributed in 600-1000nm; while the BCN particles without ethanol separation were uneven in size, mainly distributed between 200-700nm and 1-10μm, which seriously affected the mechanical properties of dental composite resins. Because large-particle fillers make it difficult to polish the resin, it is impossible to ensure a smooth resin surface, and more importantly, it may reduce the mechanical properties and wear resistance of the composite resin.

[0158] Finally, it should be noted that the above embodiments are only used to illustrate the technical solutions of the present application, rather than to limit it. Although the present application has been described in detail with reference to the aforementioned embodiments, those skilled in the art should understand that they can still modify the technical solutions described in the aforementioned embodiments, or make equivalent replacements for some of the technical features therein. However, these modifications or replacements do not deviate the essence of the corresponding technical solutions from the spirit and scope of the technical solutions of the embodiments of the present application.

Claims

1. Application of graphite carbon nitride as a photodynamic antibacterial agent in dental light-cured composite resins.

2. A dental composite resin having photodynamic antibacterial effect, characterized in that: It includes the graphite phase carbon nitride as described in claim 1.

3. The dental composite resin with photodynamic antibacterial effect according to claim 2, characterized in that: It also includes a reinforcing filler; the total weight of the graphite carbon nitride and the reinforcing filler accounts for 65-75wt% of the dental composite resin.

4. The dental composite resin with photodynamic antibacterial effect according to claim 2, characterized in that: The weight ratio of the graphite phase carbon nitride to the reinforcing filler is 1:(6-69).

5. The dental composite resin with photodynamic antibacterial effect according to claim 2, characterized in that: The weight percentage of the graphite phase carbon nitride in the dental composite resin is 1-10wt%; Optionally, the particle size of the graphite phase carbon nitride particles is in the range of 600-1000 nm.

6. The dental composite resin with photodynamic antibacterial effect according to claim 3, characterized in that: The reinforcing material is barium glass powder.

7. A method for preparing a dental composite resin having photodynamic antibacterial effect as claimed in claims 2 to 6, characterized in that: The preparation method specifically comprises the following steps: firstly preparing a suspension of graphite phase carbon nitride and anhydrous ethanol, then adding barium glass powder and triethylene glycol dimethacrylate thereto, stirring evenly; adding a main initiator and an auxiliary initiator, stirring evenly; adding bisphenol A glycidyl methacrylate, stirring evenly, and preparing a dental composite resin.

8. The method for preparing the dental composite resin with photodynamic antibacterial effect according to claim 7, characterized in that: In the composite resin matrix, the weight ratio of the bisphenol A glycidyl methacrylate to the triethylene glycol dimethacrylate is (1-2):

1.

9. The method for preparing a dental composite resin having photodynamic antibacterial effect according to claim 7, characterized in that: The main initiator accounts for 1-2wt% of the total weight of the composite resin matrix; Optionally, the main initiator is camphorquinone.

10. The method for preparing a dental composite resin having photodynamic antibacterial effect according to claim 7, characterized in that: The co-initiator accounts for 1-2wt% of the total weight of the composite resin matrix; Optionally, the co-initiator is ethyl 4-diaminobenzoate.

Citation Information

Patent Citations

  • Novel application of graphite-phase carbon nitride as antibacterial material

    CN105028436A

  • Fucoidin carbon quantum dot, preparation method and application of fucoidin carbon quantum dot in root canal disinfection

    CN114940488A